PSYCH: The Psychedelics as Medicine Report 2nd Edition
- PublishedNovember 2025
Overview
Essential reading for investors and researchers. Get analysis on the global psychedelics market, including psilocybin, MDMA and ketamine.
What’s inside
- Medical psychedelics are rapidly disrupting the way we view modern healthcare. Once the darling of the medical community, medical psychedelics are experiencing a renaissance, pushing forward the frontiers of healthcare innovation.
- PSYCH: The Psychedelics as Medicine Report 2nd Edition presents unparalleled insights and intelligence into this emerging movement, helping to guide investors, operators and regulators through this transient phase. Download your free copy now.
- The early-stage development of the psychedelics industry
- Deep dives into the most transformative compounds and companies
- Regulations, trends and commercial opportunities that will shape the market
Key findings
- The importance of education
- Stability and Consistency
Frequently asked
After checkout we email the files to your billing address, normally within one business day. This is a manually-fulfilled order so a member of our team confirms every delivery personally.
Reports are delivered as a designed PDF; datasets as CSV/XLSX. The exact formats for this product are listed in the buy box.
Purchases include a single-user licence for internal use. For team, enterprise or redistribution licences, get in touch and we’ll arrange it.
Yes — a VAT invoice is issued automatically on purchase, suitable for expensing or procurement.
Because reports are digital deliverables, sales are final once the files have been sent. Contact us before delivery if you have any questions about fit.
Get the full report
Every figure, the full market model and the complete analysis — delivered straight to your inbox.
- Full report (digital)
- Instant VAT invoice
- Single-user licence